Repligen (RGEN) Free Cash Flow Growth (1y) (2011 - 2026)
Powered by 
Analysis
Repligen (RGEN) Free Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | 16.06% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 69.50% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | -21.08% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 56.67% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | -6.83% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | -5.79% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 27.54% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -4.61% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 28.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.54% |
| Mar 31, 2026 | 106.13% |
| Dec 31, 2025 | -47.82% |
| Sep 30, 2025 | 2.50% |
| Jun 30, 2025 | -42.46% |
| Mar 31, 2025 | -68.53% |
| Dec 31, 2024 | 87.10% |
| Sep 30, 2024 | 37.26% |
| Jun 30, 2024 | 42.53% |
| Mar 31, 2024 | 1,274.74% |
| Dec 31, 2023 | -56.61% |
| Sep 30, 2023 | 4.37% |
| Jun 30, 2023 | 28.89% |
| Mar 31, 2023 | 164.65% |
| Dec 31, 2022 | 136.79% |
| Sep 30, 2022 | 154.94% |
| Jun 30, 2022 | -3.82% |
| Mar 31, 2022 | -343.80% |
| Dec 31, 2021 | 402.44% |
| Sep 30, 2021 | -34.56% |